Biostrand (A Subsidiary Of Ipa)

Biostrand (A Subsidiary Of Ipa) company information, Employees & Contact Information

BioStrand, a subsidiary of ImmunoPrecise Antibodies (IPA), operates at the intersection of biotech, life science, (bio)informatics, and AI. Our unique capabilities allow us to analyse large data sets with remarkable accuracy, providing groundbreaking insights in therapeutic and diagnostic research. Our patented HYFT technology and LENSᵃⁱ ™ Integrated Intelligence Platform make it possible to apply these capabilities across numerous life science disciplines. We are deeply committed to developing a next-generation end-to-end omics drug development platform that harnesses our advanced tools to accelerate discoveries. Let’s collaborate today. https://www.biostrand.ai
Looking for a particular Biostrand (A Subsidiary Of Ipa) employee's phone or email?

Biostrand (A Subsidiary Of Ipa) Questions

News

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... - Yahoo Finance

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... Yahoo Finance

IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies - Investing News Network

IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies Investing News Network

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence - Business Wire

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence Business Wire

IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market - BioSpace

IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market BioSpace

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - FinancialContent

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 FinancialContent

European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology - FinancialContent

European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology FinancialContent

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - Business Wire

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” Business Wire

Top Biostrand (A Subsidiary Of Ipa) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant